Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Drugs and Devices	7.13B	7.79B	7.96B	12.21B	20.95B
Sales of Mobile Medical Software and Services	45.75M	68.41M	52.34M	77.20M	86.88M
Lease	28.56M	24.13M	25.42M	22.72M	19.14M
Sales of Other Products	95.10M	86.82M	-	-	-
Total	7.30B	7.97B	8.03B	12.31B	21.06B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	7.30B	7.97B	8.03B	12.31B	21.06B
Total	7.30B	7.97B	8.03B	12.31B	21.06B

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error